Diabetic Macular Edema Market size worth $ 4.87 Billion, Globally, by 2028 at 2.86% CAGR: Verified Market Research®

JERSEY CITY, N.J., Oct. 7, 2021 /PRNewswire/ -- Verified Market Research recently published a report, "Diabetic Macular Edema Market" By Product (Anti VEGF Therapies, Corticosteroid Therapies), By Product Form (Intravitreal Injections and Intravitreal Implants), By Distribution Channel (Retail Pharmacies and Hospital Pharmacies), and By Geography. According to Verified Market Research, the Global Diabetic Macular Edema Market size was valued at USD 2.92 Billion in 2020 and is projected to reach USD 4.87 Billion by 2028, growing at a CAGR of 2.86% from 2021 to 2028.

Verified_Market_Research_Logo

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=183965

Browse in-depth TOC on "Diabetic Macular Edema Market"

202 - Pages

126 – Tables

37 – Figures

Global Diabetic Macular Edema Market Overview

Diabetic macular edema is caused by a variety of factors, which necessitates a thorough understanding of the disease's pathophysiology and molecular mechanisms. In recent years, pharmaceutical companies have targeted combinations of multiple medicines for the treatment of DME, aiming to target separate routes or different steps of the same process. Medication and laser surgery are two well-established treatments targeted at keeping the patient's vision and reducing future vision loss.

The growing prevalence of chronic conditions such as diabetes is driving the global Diabetic Macular Edema Market. Diabetic Macular Edema is a highly common indication, and innovative medications are being developed to treat it. Diabetic macular edema is caused by a variety of factors, which necessitates a thorough understanding of the disease's pathophysiology and molecular mechanisms. In recent years, pharmaceutical companies have targeted combinations of multiple medicines for the treatment of DME, aiming to target separate routes or different steps of the same process.

Key Developments in Diabetic Macular Edema Market

  • In May 2021, Faricimab (Roche), KSI 301 (Kodiak Sciences Inc.), and Beovu (Novartis) late-stage products have shown promising results in diabetic macular edema and are expected to improve the dosing interval.

The major players in the market are Pfizer Inc, Allergan PLC, Novartis AG, Clearside Biomedical Inc, Ariam Pharmaceuticals, Valeant Pharmaceuticals, Regenron PLC, Bayer AG, pSivida Corporation, Alimera Sciences Inc.

Verified Market Research has segmented the Global Diabetic Macular Edema Market On the basis of Product, Product Form, Distribution Channel, and Geography.

  • Diabetic Macular Edema Market, By Product
    • Anti VEGF Therapies
    • Corticosteroid Therapies
    • Other Off-label Drugs
  • Diabetic Macular Edema Market, By Product Form
    • Intravitreal Injections
    • Intravitreal Implants
  • Diabetic Macular Edema Market, By Distribution Channel
    • Retail Pharmacies
    • Hospital Pharmacies
  • Diabetic Macular Edema Market by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Eye Health Supplements Market By Ingredient (Lutein and Zeaxanthin, Antioxidants, Omega-3 fatty acids, Coenzyme Q10), By Indication (Age-related Macular Degeneration (AMD), Cataract, Dry Eye Syndrome), By Form (Tablet, Capsule, Drops), By Geography, Forecast, 2020-2027

Autoinjectors Market By Product Type (Disposable Auto-Injectors, Reusable Auto-Injectors), By Application (Anaphylaxis, Multiple Sclerosis, Diabetes), By End-User (Home Care Settings, Hospitals And Clinics), By Geography, Forecast, 2020-2027

Human Insulin Market By Application (Type I Diabetes and Type II Diabetes), By Delivery Device (Syringes, Pens, Pen Needles), By Brand (HI Analogs & Biosimilars and HI Biologics), By Type (Insulin Analogs & Biosimilars and HI Biologics), By Product Type (HI Drugs and HI Delivery Devices), By Geography, Forecast, 2020-2027

Autoimmune Disease Therapeutics Market By Drug (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Anti-inflammatory, Interferons, Antihyperglycemics), By Disease (Multiple Sclerosis, Rheumatoid Arthritis, Inflammatory Bowel Disease, Type 1 Diabetes), By Geography, Forecast, 2020-2027

Top 10 antidiabetics pharma companies stopping the silent killer: Sugar rush

Visualize Diabetic Macular Edema Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us
Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Cision View original content:https://www.prnewswire.com/news-releases/diabetic-macular-edema-market-size-worth--4-87-billion-globally-by-2028-at-2-86-cagr-verified-market-research-301395144.html

SOURCE Verified Market Research

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.